Stéphane Bancel

Moderna sprints toward RSV podium behind GSK, Pfizer

Moderna is charging ahead in the RSV race behind leaders Pfizer and GSK, looking to claim a critical bronze medal in the potential $10 billion market.

Max Bayer Jan 4, 2023 3:37pm

Moderna CEO: Mpox vaccine development is not a high priority

Jan 4, 2023 9:49am

Moderna's Bancel has 'never been as busy' amid M&A talks

May 4, 2022 11:19am

Moderna's CMO Zaks quits for 'next leg of his career'

Feb 25, 2021 7:23am

Moderna finalizes design of phase 3 COVID-19 vaccine trial

Jun 11, 2020 8:45am